Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

5 mcg/kg for 21 days. Injected subcutaneously once daily. Progression to the next dose level based on safety data

5 mcg/kg for 7 days followed by 10 mcg/kg for 14 days. Injected subcutaneously once daily. Progression to the next dose level based on safety data

5 mcg/kg for 7 days followed by 10 mcg/kg for 7 days followed by 15 mcg/kg for 7 days. Injected subcutaneously once daily

Liraglutide placebo administered to subjects randomised at each dose level in the ratio of 3:1